Prezent

PrezentPrezent
Prezent

Prezent

AI-powered platform for creating and delivering engaging presentations.

DR 632021Active362Tel Aviv, Israel
Rate

About

Prezent is an AI-native communications partner for the life sciences industry, offering a platform that fuses AI and human expertise to create brand-compliant, executive-grade presentations. Their solutions, including self-serve AI, agentic workflows, overnight presentations, and fixed-price projects, serve biopharma companies and specialized agencies. Prezent aims to accelerate the process of moving science to market through efficient and impactful communication.
Frequently asked

What does Prezent do?

Prezent is an AI-native communications partner for the life sciences industry, offering a platform that fuses AI and human expertise to create brand-compliant, executive-grade presentations. Their solutions, including self-serve AI, agentic workflows, overnight presentations, and fixed-price projects, serve biopharma companies and specialized agencies. Prezent aims to accelerate the process of moving science to market through efficient and impactful communication.

What is Prezent's revenue?

StartupHub estimates Prezent's annual revenue at $20.1M (range $6.6M to $47.2M, 27% confidence), based on comparable companies in the sector.

What is Prezent's valuation?

StartupHub estimates Prezent's effective valuation at $331.6M (range $232.1M to $431.0M, 37% confidence), based on comparable companies in the sector.

How much funding has Prezent raised?

Prezent has raised a total of $54M in funding. The most recent round on record is Series A extension.

Where is Prezent headquartered?

Prezent is headquartered in Tel Aviv, Israel.

When was Prezent founded?

Prezent was founded in 2021.

What industry does Prezent operate in?

Prezent operates in AI Tools & Apps, Generative AI, Presentation Software, Productivity Software, B2B SaaS.

How many employees does Prezent have?

Prezent has approximately 362 people on record.

HEADCOUNT
362
DOMAIN RATING
63
Comments

No comments yet. Be the first to share your take.